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EFFDCT OF INJECTING OF CHROMATINS FROM RHODAMINE SARCOMA INTO RATS ON
pI―ISOZYMES OF LIVER PYRUVATE KINASE
ADDENDUM : PURIFICAT10N AND PROPERTIES OF M2~IYPE PYRUVATE KINASE
FROM RHODAMINE SARCOMA
by
Tos■kazu NAKAMURA
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SUMMARY
The pyruvate kinase present in extracts from var■ous tissues of rats has
been separated into five pI―■sozymes by isoelectr■c fra ionation, the
isoelectric points (pI)of which are 5。4, 6。1, 6。5, 7.4 nd 7.8。  Extracts from
skeletal muscle, heart muscle and bra■n conta■n only p1 7.4-■sozyme, Whereas
extracts from liver, spleen, lung, erythrocyte, kidney and Rhodamine sarcoma
conta■n three to four different pI―■sozym s。  Of the pI―■sozymes present in an
extract from each kind of tissue, the pI―■s zyme highest in relative activ■ty
is p1 5。4-isozyme for liver, P1 6.5-isozyme for spleen, lung and erythrocyte,
and p1 7.8-■sozyme fOr kidney and Rhodam■ne sarcoma.  The kinetic character■stics
of the five pI―■sOzymes are different from one anothere  The growth of the tumor
on the back of rats br■ngs about a sign■ficant increase of the activ■ty of pyruvate
kinase ■n the livers; the p1 6。1-■sozyme ■ncreases, whereas the other pI―■sozymes
are hardly influencedo  When a preparation of chromatins from Rhodamine sarcoma
has been ■njected intO rats, the activ■y of pyruvate kinase ■n the livers
■ncreased to a sign■ficant extent; approx■mately 60 % of the ■ncreased activ■ty
is due to the p1 7.8-isozyme, the remainder due to the p1 6.1-isozyme.
INTRODUCT10N
A multiplicity in type of pyruvate kinase was first reported by Tanaka
e夫^alf 19), who have shown, us■ng rats, that most of the pyruvate kinase present
■n livers ■s of type L, whereas all the enzyme present in the rat muscles ■s
of type M; these two types are distinguishable electrophoretically, immunologically
and kinetically.
In the present study, extracts from var■ous tissues of rats and from
Rhodam■ne sarcoma grown ■n rats were subjected to ■soelectr■ fractionation●
(2)
with Ampholine carrier―ampholytes with attempts to examine the kinds and the
relative activities of pI―sozymes of pyruvate kinasee  Livers from Rhodamine
sarcoma―bear■ng rats, and those fron the rats that had been ■njected w■h
chromatins prepared from the tumor were also examined with respect of the
pI―■sozymes.
METHODS AND MATERIALS
Animals and Tumor     Adult male albino rats of the Donryu strain were fed on
an ordinary laboratory diet (Oriental Yeast Co。, Ltd。, Osaka)with unlinited
supply of water, and those weighing around 150 g were used for experiments.
In some cases, rats were fed on the high carbohydrate diet, which was cOmposed of
62 % glucose, 31 % casein, 1 % the vitamin mixture (see below), 4 % the salt
mixture (see be10w), 0。ol% choline chloride and 2% cellulose powder.19)
Transplantation Of Rhodam■e sarcoma on the back of rats was carr■ed out a
described previously。12) Normal and tumor…bearing rats were decapitated, and
then the var■ous organs and the tumor were dissected outo  The tumor tissues
that had been freed of necrotic parts were used as tumor sampleso  Livers were
homogenized in an equal volume (v/w)of O。1′vぃTriS―HCl buffer (pH 7。5)containing
5 mM ethylenediam■ne tetraacetate and 10 1般:β~mercaptoethanol w■th the use of
a Potter―Elvejhem homogenizer.  Other tissues were treated in the same manner
as livers, except that the volumes of the buffer were varied.  Nine volumes (v/w)
of the buffer was used for skeletal muscles and Rhodam■ne s rcoma, and four
volumes (v/w)of the buffer for the other tissues.  The homogenates were centri―
fuged at 105,000^g、for lュニ.  The resulting supernatants are called "extracts",
and were used for analys■s by isoelectr■c fractionation and for the activ■ty
●(3)
assay,of pyruvate kinase.  All the procedures were carr■ed Out in a cold room
(approximately 4°).
Activ■ty Assay of Pyruvate Kinase     The activ■ty of pyruvate kinase was measured
according to the method of Biicher and Pfle■derer。 ) T  standard reaction
mixture was cOmposed of O◆5 ml of O.1´りぃTris_HCl buffer (pH 7.5), 0.l ml of
20 1M^phOSphoenolpyruvate, 0。 ml of 20 1MらADP, 0。l ml of l。5 M KCl, 50 11l of
O.2′y、Mgc12' 50 μ1 0f 5 1M、NADH, 10 ■l of 150-200 units/ml of lactate dehydro―
genase (2-laCtate:NAD+ Oxidoreductase, EC l.1.1.28)and water to make the total
volume l。O mlo  The reaction was started by adding 10 or 20 1tl of an enzyme sample
to the standard reactiOn m■xture, and the decrease of absorbancy at 340 コロ
was measured at 24°。 One unit Of pyruvate kinase was defined as the amount of
the enzyme that caused the ox■d tion of l μmol f NADH per m■n.
Activ■ty Assay of Catalase     The catalase activ■ties of liver homogenates were
measured in the presence of O.3 96 Tr■tOn x_100 according to the method descr■bed
previously。12)
Preparation Of Chromatins from Rhodamine sarcoma and lnjection of the Chromatins
■nto Rats     ChrOmatins were prepared from Rhodam■n sarcoma acc rding to the
method of Clark´et al^.4)and Chalkley e夫ら鳴・
3)with some modifications.  All
the preparation procedures were carr■ed out O-5°.  Rhodam■ne sa coma tissues
at the frozen state were blended in 9 v01umes (v/w)of 5 1y、Tris_Hcl buffer
(pH 7.5)containing O。25 M sucrose and 3 mM CaC12 With the use of a Waring blendor,
and then filtered through a stainless steel net (hole size, l x l mm)to remove
fibrous partso  The filtrate was centrifuged at l,200 g foF 20 min.  The resulting
precipitate was centrifugally washed twice in each with 9 volumes (v/w)of O。l M
Tris―HCl buffer (pH 7.5)containing O。15 M NaCl, and then twice in each with
―
●
“(4)
9 volumes (v/w)of O。1鳳TriS―HCl buffer (pH 7。5)containing 20 mM ethlene―
diamine tetraacetate and 80 mM NaCl (pH 7.5).  The washed precipitate was suspended
in 9 volumes (v/w)of water, and then sonicated at 10 kc for 5 min, folloWed by
centr■fugation at 12,000 g for 30 m■no  The resulting supernatant was supplemented
with such an amount of NaCl that the concentration Of the salt would be O.15 M.
The m■xture was stirred for 90 m■n, followed by centr■fugation at 12,000 g for 30 m■n
The resulting precipitate was suspended in 9 volumes (v/w)of water.  The suspension
thus obta■ned was used as a preparation of chromatins.  The chromatin preparation
was analyzed to contain 5。00 mg/ml of DNA, 0。35 mg/ml of RNA and 15。5 mg/ml of
protein.  It (2.O ml)was injected into the subcutaneous region on the back of
each rato  For the control, 2。O ml of NaCl solution was injected.  The injected
rats were kept for 23 hr with unlimited supply of water and diet.  They were then
decapitated, and the■r livers were dissected out and used.
Determ■nation of Contents of Prote■n, DNA and RNA     The content of prote■n was
determined by the method of Lowry et al」11)With the use of human serum albumin as
the standard.  The content of DNA was determ■ned by the diphenylam■ne r action
of Schneider 6), and the cOntent of RNA by the orcinol reaction 6), with the
use of herr■ng sperm DNA and yeast RNA as the standards, respectively.
ISOelectric Fractionation with Ampholine―carri皇二 生里⊇LΩllteS     The isoelectric
fractionation on an electrofocus■ng column f pyruvate kinase present in extracts
from var■ous tissues of rats were carr■ed out ac o ding to the method of Vesterberg
and Svensson20); the prOcedure used was the same as that described previously.14, 15)
OthersSodium phosphoenolpyruvate and ADP were purchased from Sigma Chemical
Co。, St. Louis, Missourio  Lactate dehydrogenase and NADH were commercial products
of Boehr■nger Mannhe■m GmbH, Mannhe■m a d Or■ntal Yeast Co。, Ltd。, Osaka,
respectivelyo  The salt m■xture, the vam■n xture, case■n, choline chlor■de●
(5)
and cellulose powder used for the high carbohydrate diet were obtained from
Tanabe Pharmaceutical Co。, L d。, Osaka.
RESULTS
SuttIQx Of pIIISOZymes of PyruvatQ Kinase Present in Var■ous Tissue  of Rat
When extracts from var■ous tissues and Rhodam■ne sarco a of rats were
subjected to ■soelectr■ fractionation, the pyruvate kinase present was
separated into five fractions, which were distinctly different in ■soelectr■
POintS (pI)and easily separable from one another.  The enzymes present in these
fractions are called ''pI―isozymes"14,15) Typical results obtained with
extracts from liver, spleen, muscle and kidney of a normal rat and w■th an extract
from liver of a tumor―be ring at are shown in Fig。 1。  The enzyme was remarkably
Fig. 1
stable aga■nst the ■soelectr■ fractionation; the yields ■n all th  cases were
as high as 100 %.  The pI―activity curve with the extract from normal rat liver
has four peaks corresponding to p1 5。4-, p1 6。1-, p1 7。4- and P1 7.8-isozymee
Of the fOur, p1 5。4-isozyme is highest in relative activity.  Although the
same four pI―■sozymeS are present in the extract from normal rat kidney,
p1 7.8-isozyme is highest in relative activity with the kidney extract.
The enzyme present in the spleen extract also ■s separated into four pI―■sozymes;
instead of p1 5.4…isOzyme is present p1 6。5-isozyme, highest in relative activitye
Only p1 7。4-■sozyme ■S seen w■th the extract from skeletal muscle.  Essentially
the same results were obtained with male rats of the Sprague―Dawley st in and
the Wistar stra■n; the pI―ctiv■ty curves remarkably resembled those w■th the
rats used in this ser■es of exper■ments.
(6)
Normal rats fed on the high carbohydrate diet for 72 hr were approximately
three times as high in the activity of liver pyruvate kinase as normal rats
fed on the ordinary labolatory diete  To the contrary, the activ■y was appro―
x■mately one―half when rats had been starved for 24 hr。 Of the four pI―■sozymes
present in extracts from normal rat livers, only the p1 5.4-■sozyme Wa  f und
to be significantly influenced in activity by the dietary conditions (Fig。 2).
Fig. 2
The relative activ■ties of the pI―■sozymes of pyruvate kinase present in
extracts from var■ous tissues and Rhodam■ne sarco a of rats, and the yields ■n
isoelectric fractionation are su■lm r zed in Table I.  The enzyme was remarkably
Table I
stable in isoelectric fractionation; the yields in all the cases are as high
as 100 %.  The sucrOse used for making the dens■ty gradient in the electro―
focus■ng column, probably, were of advantage to the stabilization of the enzyme.
In extracts from tissues of normal rats, lung and erythrocyte, bes■des sp een,
show the highest relative activity of p1 6。5-isozyme.  As is in the extracts
from skeletal muscle, other isozyme than p1 7.4¨isozyme is see neither in
the extract from heart muscle nor in the extract from braino  The extract from
Rhodam■ne sarcoma has P1 6。1-■sozyme, p1 7。4-■sozyme and P1 7.8-■sozyme; Of
these three, the p1 7。8-isozyme is highest in relative activity。 Of the xtracts
from var■ous tissues of rats so far exam■ned, the extract from skeletal muscle
showed the highest specific activity of the pyruvate kinase`
Kinetic properties of the five pI―■sozyme of pyruvate kinase are summar■zed
in Table II。 Of the fractions Of one pI―isozyme obtained by isoelectric fractio―
●
Table II
●(7)
natiOn of an extract from each kind Of tissue, the fraction show■ng the highes
activ■ty was used as a sample of the pI…■sozyme. T same pI―■sozyme was prepared
from var■ous kinds of tissues.  For example, enzyme samples used for p1 6.1-
isozyme, p1 7.4-isozyme and P1 7.8-isozyme were obtained from kidney.  Although
different kinds Of tissues were used for preparation of each of the five pI―
■sozymes, no difference ■n th  kinetic properties has been found among var■ous
sources of the respective pI―■sozymeso The Km values for ADP are O。1-0.4 mM
for all the five pI―isOzymes.  With p1 5。4-isozyme and p1 7。4-isozyme, the Km
values for phosphoenolpyruvate are 60,M with the Hill con〔:tant (n)= 1。0; the
reaction rates are accelerated by fructose l,6-diphosphate at var■ous concentrations
of phosphoenolpyruvatee  With the other pI―■sozymes, the cu ves for ■n■tial rate
興 phOSphOenolpyruvate concentration were of sigmoid shapes; with p1 6。1-
■sozyme, p1 6。5-■sozyme and P1 7.8-■sozyme, th()n valuetC are l.3, 1.8 and l。4,
respectively, and the liapparenti' Km values for phosphoenolpyruvate (the substrate
concentrations for half the rates at sufficient concentrations of the substrate)
are l-2 ■11 0。2 mttt and l lMぇ respectively.  In the presence of phosphoenolpyruvate
of O.1 型遅L whiCh iS lower than the K面 values, the activities of p1 6.1-isozyme
and p1 6.5-isozyme were 27 times and 12 times stimulated by adding O.l mM fructose
l,6-diphosphate, respectively.  The activity of p1 7。8-isozyme is hardly stimulated
by fructose l,6-diphosphate, in spite of that the curve for ■n■tial rate versus
phosphoenolpyruvate concentration was Of a sigmoid shape and the l:apparent‖ Km
value for phosphoenolpyruvate is as high as l mM.
In a g00d accordance w■th the description by Hess and Kutzbach6), p1 5.4-
■sozyme and P1 6。1…■sozyme were convertible ■n a revers■ble mannero  When all
the pyruvate kinase present in extracts from livers of normal rats was precipitated
by 70 %―saturated ammon■um sulfate at pH 7 w■thout addition of fructose l,6-
(8)
●
diphosphate and the resulting precipitate was then subjected to ■soelectr■
fractionation, the amount of p1 6。1-■s zyme ■ncreased; the ■ncrease was ■n
parallel w■th the decrease ■n amount of the p1 5。4-■sozyme that had been obta■ned
before the treatment.  In the oppos■e way, p1 5.4-■sozyme Was obta■ned by
electrofocusing of a mixture of p1 6.1-isozyme and fructose l,6-diphosphate.
It is conceivable, therefore, that p1 5.4-isozyme is the p1 6。1-isozyme that has
been assoc■ated W■th fructOse l,6-diphosphate.
Effect of lnjectiOn Of Chromatins Prepared from Rhodam■ne arcOm  and Growt
Of ttLQ IIhmor on lsOzyme Pattern of Liver Pyruvate Kinase
When Rhodam■ne sarcOma grew on the back of rats, the activ■ty of pyruvate
kinase of the livers increased to a significant extent.  In the average of five
experinents, the activity increased t0 165 % (Table III)。  In the isOzyme pattern,
Table III
the p1 6。1-■sozyme ■ncreases markedly, wherea the other pI―■sozymes are hardly
influenced (see also Fige l)。  M re that 70 % of the increased activity is due
to the ■ncrease of the p1 6。1-■sozyme,the rema■nder due to the ■ncrease of
the p1 5.4-isozyme。
When chromatins prepared from Rhodamine sarcoma were injected into rats,
the activity of pyruvate kinase of the livers  increased to the same extent as
when the tumor grew on the back of rats (Table III).  In the pI―isozymes
patterns, there are, however, marked differences between the ■njecte  and the
tumor―bear■ng rats.  In the livers of the ■njected rats, p1 7.4-■sozyme and
p1 7。8-■sozyme ■ncrease by two times and by three times, respectively, whereas
both the pI―■sOzymes are not influenced in the livers of the tumor―bear■ng rats.
The only s■m■larty between the ■nject d and tumor―bear■ng ats ■s that p1 6.1-●
(9)
?
?
?
?
?
?
?
?
?
■sozyme ■ncreases ■n both cases.
In chromatin―■njected rats, the catalase activ■ty of th livers decreased
a significant extent, in a good accordance with the findings with the use
micel°)(Table lv).  The catalase activity of the tumor tissues was negligiblee
Table IV
DISCUSS10N
Tanaka″£贅t al・ 9)have succeeded in preapration of crystalline, pure pyruvate
kinase from skeletal muscles and livers of rats, and demonstrated that the antiserum
aga■llst the muscle enzyme neutralizes the activ■ty of the muscle enzyme, but not
the activity of the liver enzyme, and vice versa。  On the basis of the findings,
they proposed to classify the enzyme into type M and type Lo  The enzyme of the
type M displays Michaelis―Menten kinetics with respect to phosphoenolpyruvate.
On the Other hand, the enzyme of the type L displays sigmoid kinetics with respect
to phosphoenolpyruvate, a1loster■c ctiv ti n by fructose l,6-diphosphate and
inhibition by ATP.  Suda et al.17)have shown that the enzyme of the type M increased
in livers of rats bearing Walkeris sarcoma.  Susor and Rutter18)claimed that in
electrophores■s on a cellulose acetate membrane, the pyruvate kinase of the type M
present in rat liver was different from the enzyme of the type M present in rat
skeletal muscle; the■r cla■m was recently suppoeted by the kinetic study of
」imёnez de Asta。′et al.9).  In the present study, it was found that by isoelectric
fractionation, the pyruvate kinase present in var■ous tissues of rats was separable
■nto five ■sozymes, the pl values of which were 5.4, 6.1, 6。5, 7.4 and 7。8。 The
relative activ■ties of these pI―■sozymes ■n var■ous tissues were also measured.
Skeletal muscle, heart muscle and bra■n pos essed only p1 7.4-■sozyme, the kinetic●
●(10)
properties of which were essentially the same as those of the enzyme of the type M
characterized by Tanaka et al。19) This p1 7.4-isozyme is, therefore, doubtless to
be of the type M.  Cr■ss )also carr■ed out isoelectr■c fractionation of an extract
from skeletal muscle of rats, and reported that the pyruvate kinase present was
of p1 6。75。  At the present time, the difference between his and our data on the
pl value is not explainable; in the present study, the pl values of isozymes were
accurate w■hin O.l in several times―r peated xper■m nts w■th the use of rats
of three different stra■ns.  The p1 7.8-■soZyme Was most abundant in kidney, of
the tissues of normal rats testedo  lt is feas■ble that p1 7.8-■soZyme ■S of the
type M2 Classified by lmamura fttL al・ ), Who have shown that the activity of this
■sozyme ■s neutralized by the antiserum aga■nst the type M enzyme.  In livers
of normal rats fed on an ordinary laboratory diet, the activ■ty of p1 7.8-■sozyme
was 15 % of the total activity of all the four pI―isozymes present, three times
as high as the activ■ty of p1 7.4-■sozyme.  In compar■s■on to the tissues of rats
examined, Rhodamine sarcoma showed a relatively high activity of pyruvate kinase,
approx■mately 80 % of which was due to p1 7.8-■sozyme; the activ■ty of the ■sozyme
per mg protein in the tumor is highest, four times as high as that in kidney.
Nakamura′喪 a10(tO be published)have recently succeeded in preparation of
crystalline, pure p1 7。8-■sozyme from Rhodam■ne sarcoma.
The ex■stence of p1 6。5-■sozyme Of pyruvate kinase was first observed in
the present study.  Spleen of normal rats possessed four pI―■sozymes: 78 % of
the total activity of all the pI―isozymes was due to the activity of p1 6.5-
■sozyme。 Of the pI―■soZymeS present in the extracts from var■Ous tiSSues of
normal rats tested, the p1 6.5-■sozym resent in the extract from spleen was
highest both in relative activity and in specific activity (U/mg protein);
●(11)
thus, it is called the type S enzyme tentatively.  The tissues other than spleen,
lung and erythrocyte did not possess the type S enzyme。
It is doudtless that p1 6.1-isozyme of pyruvate kinase, when so tightly
bound with fructose l,6-diphosphate that the bound fructose l,6-diphosphate
would not be dissOciated from the enzyme molecule by the electrofocusing
procedure for ■soelectr■ fractionation, is converted into p1 5.4-■sozym .
The kinetic properties of p1 6.1-■sozyme were essentially the same as those of
the type L enzyme・9); thus, it may be appropriate to classify p1 5。4-isozyme into
the type Li.  In fresh extracts from livers, almost all the type Li seen after
■soelectr■ fractionation ■s, perhaps, present at the form of the type L, at which
the binding between the enzyme molecule and the fructose l,6-diphosphate under
the ■ntracellular conditions ■s ot s  tight as descr■bed above; the kinetic
behav■ors of pyruvate kinase, when assayed w■th fresh preparations of extracts
from livers of normal rats, were essentially the same as the sum of those of each
of the pI―isozymes, if calculatiOn was made under the assumption that the type L'
obtained by isoelectric fractionation had been present as the type L in the
extracts.  The conversion of the type L into the type L' during the period of
electrofocus■ng of the extracts may take place as follows: In liver cells, the
concentration of fructose l,6-diphosphate is approximately O。5 mM (Hoso  et al.,
to be published), but the enzyme molecules of the type L are not bound with
fructose l,6-diphosphate tightly because of the sufficiently high ionic strength
of the salts presento  When an extract from the cells ■s subjected to ■soelectr■
fractionation, the salts migrate apart from the Zone of the enzyme molecules
gradually dur■ng the per■od of electrofocus■ngo  When the on■c strength of the
zone is lowered to an appropriate extent, the enzyme molecules are bound tightly
w■th the fructose l,6-diphosphate molecules that have still rema■ned at a lower
0
(12)
concentration in the zone.  It seems conceivable, therefore, that the type L'
■s the artifact, and that in the cells of tissues, the ■sozyme molecule  of the
type L are associated with fructose l,6-diphosphate such weakly that the extent
of the association depends On the concentration of fructose l,6-diphosphate
in a reversible mannero  The ratio in activity of the type Ll enzyme to the
type L enzyme obta■ned by isoelectr■c fractionation of an cell extract, poss■bly,
depends mainly on the concentration of fructose l,6-diphosphate present in the
cells; the higher the concentration, the higher the ratio.
The pyruvate kinase present in livers of normal rats was separable ■nto
type LI, type L, type M and type M2・  By dietary conditions of rats, the type LI
and the type L were influenced to a significant extent, but nOt the other types。
The activities of the type L' enzyme and the type L enzyme, and the ratio in
activity of the type Ll enzyme to the type L enzyme increased when rats had been
fed on a high carbohydrate diet, whereas they decreased, when rats had been
starvedo  Dietary conditions of rats, doubtless, change the concentrations of
var■ous metabolites ■n th  liver cellso  lt is probable, therefore, that the
■ncreased and decreased concentrations of phosphoenolpyruvate ■n liver cells
are respons■ble for the ■ncrease and decrease ■n amount of the type L enzyme
■n the cells, respectively, and that the ■ncreased and decreased concentrations
of fructose l,6-diphosphate ■n the extr cts are respons■ble for the ■ncr ase
and decrease in the ratio in activity of the type L: isozyme to the type L
■sozyme, respectively.
When chromatins prepared from Rhodamine sarcoma were injected into normal
rats, the activ■ty of liver catalase decreased to 76 %, whereas the activ■ty
of liver pyruvate kinase ■ncr ased to 154 %.  Approx■mately 40% and 60 % of
●
←(13)
the ■ncreased activ■ty of the enzyme were due to the ■ncrease of the activ■ty
of the type L enzyme and the type M2 enzyme, respectively.  In Rhodamine sarcoma―
bear■ng rats, the activ■ty of liver pyruvate kinase was 160% of that in normal
rats.  Approx■mately 80% and 20 % of the ■ncreased activ■ty of the enzyme were
due to the increase on the activity of the type L enzyme and the type Li enzyme,
respectively.  On the other hand, in Rhodamine sarcoma tissues, approximately
80 % of the activ■ty of pyruvate kinase was due to the activ■ty of the type M2
enzyme.  One of the possible explanation for this may be as follows.
Either ■njection ■nto rats of chromatins prepared from Rhodam■ne s coma
or bear■ng of Rhodam■ne sarcoma on the back of rats br■ng ab ut the■ncrease ■n
concentration Of phosphoenolpyruvate, but not fructose l,6-diphosphate, in the
livers, so that the amount of the type L enzyme ■ncreased, leavlng the amount
of the type Li enzyme unchanged.
It is prObable that the high relative activity of the type M2 enzyme in
the tumor tissue and the ■ncre s e ■n activ■ty of the ■sozyme ■n the livers
of rats ■njected w■th the chromatins were ■nvOked by the same causee
Matuo′£t E1013)solubilized and purified the liver catalse―n v■o―depressing
substance [toxohormone(liver catalase)] from Rhodamine sarcoma tissues, and
Kannan et al。 °)demonstrated that the depress■ng substance ■s located in the
chromatins of the nucleio  Recently, Nishikawa ftt al。(to be published)have
succeeded in a complete pur■fication of the depress■ng substance; it is a
neutral protein (pl value = 7)free of nucleic acids.  There is the possibility
that the chromatins of Rhodamine sarcoma possess a regulator functional in
t'switch―onil of the biosynthesis of type M2 enzymeo  Perhaps, the regulator
■s scarcely liberated′■n v■vo from the tumor cells, different from the case
of the liver catalase―in v■o―depr ss■ng substance.
●
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Table I.  Relative Activities of pI―Isozymes of Pyruvate KinaSe Present in various Tisstles of Rats
Rats Diets Tissues
Specific
activ■ti es
■n extracts
Recover■s ■n
■soelectr■
Fractionation
Relative activitieS Of pI_isOzymes
p1 5.4  P1 6.l  p1 6.5  p1 7.4  p1 7。8
Norma1     0rdinaryLiver
Spleen
Lung
ErythrOcyte
Skeletal llluscle
lleart muscle
Bra■n
kidney
Liver
Liver
Rh.sarcOma
Liver of rat
in」ected with
Rhosarcoma
chromatins
(U/mg prOtein)
0。24
0.61
0.61
0。02
8。9
0。95
1。9
0.56
0。70 -
0。40
1.4
0。33
,,
,,
9,
,,
9,
,9
|'
9,
9,
・    ,,
,,
,9
,,
(%
90
91
103
104
95
87
95
115
70
96
90
85
(,`)
65
0
0
11
0
0
0
7
85
37
0
40
(%)
14
5
0
9
0
0
0
32
9
45
13
22
(9`)
0
78
51
62
0
0
0
0
0
0
0
0
(%)
6
12
14
3
100
100
100
12
2
5
10
9
(,喀)
15
5
35
、  15
0
0
0
49
6
13
77
29
,,   High carbohydrate
Rhosarcoma―  Ordinary
bear■ng
ll           l,
NOrmal        ,9
LI S K)a)
Types of enzyme
in kidnOy, but not present in
卜12(°r
a) This typO is nlost abulldant
●
mllscl  a all.
i    ■ ●
Table IIo   Kinetic Properties of Five Types of Pyruvate Kinase of Rat
The exper■m ntal conditions were the same as those descr■bed in the text,
except that in the reaction m■xtu  for the activ■ty ssay, var■ous
concentrations of phosphoenolpyruvate and ADP were added for determ■nation
of the Km values for phosphoenolpyruvate and ADP, respectively, and var■ous
concentrations of phosphoenolpyruvate and O。1 ■M、fructose l,6-diphosphate
were added for measurement of the activation by fructose l,6-diphosphate.
Hill constants (n)for phosphoenolpyruvate were calculated on the basis of
curves of activ■ty vso phosphoenolpyruvate concentration according to the
method of Atkinson et al。1'7)
ヤ
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Table II.Kinetic Properties of Five pI―Isozymos of Pyruvate Kinase of Rats
Pyruvate kinase′pI―isozbnneS
p1 5。4 P1 6。1 p1 6.5 P17.4 p1 7.8
Km values for phosplloenolpyruvate0。06 mM 1-2耐 0。2 ?? 0。06 mM l mM
K珊 values for ADP 0。2 ??
?
?0。3
?
? 0。2嗅 0。4 ?? 0。1
IIill collstantS for
phosphoenolpyruvate 1.0 1.3 1。8 1。0 1.4
Activation by O。1 =ぷ _
fructose l,6-diphosphate
a)+++
SourcOs fOr
pI―■sozymes
used
Livёr:
NOrmal rat
Rhosarcoma
l)oaring rat
Rat injected
、ヾ■th Rhosarcoma―
chromatins
Liver: Spleen
Rh.sarcOma―   Lung
bearing ratErythrocyte
Rat inJected
w■th Rh.sarcoma―
chromatins
Kidney
Rh.sa rcoina
Kidney
Rh.sarcoma
Spleen
Liver of rat
in3ected with
Rh.sarcoma‐
chromatins
Skeletal
muscle
Heart
muscle
Brain
Kidney
a) The inhibitory offOct Of alanine lllas ill part ncutralized by adding fructose l:6-diphosphate.
●
Table III.. ComparisOn in pI―IsOzyme Pattern
bSar■ng Rat, Liver of Normal Rat
of Py uvate Kinase anlong Ltter
lnjocted with RhOdamine salヽco:n
of NtDrmal Rat, Liver Of RhOdam■ne sarcOnta―
ChrOmatins, and RhOdam■ne sarcO a Tissue
Tissues of rats
SpeCifiC
activ■ties of
pyruvate kinase
■n extracts
Amounts Of
pyruvate kinase
subjected to
■soelectr■
fracti01lat■on‐・
Number
Of
an■mals
tested
4mOuntS Obtained by isoelectriC fractiOnation
Liver oF normal rat
Liver of Rhesarcoma―
boar■ng rat    e
Liver of normal rat
in」octed with Rh.
Sarcoma Chromatins
RhOdamine SarcOma
5
5a)
(U/mg prOtein)
Oe23 1 0。ol
O。35 10。ol
O.33 1 0.01
1。40 ± 0.20
6。5
10。4
2。4
3.9
10。0 ± 3.0
21.5 ± 5。2
(U)
4.3 1 0.3
5。611。1
4。0 ± o。3
0
2。210。1‐
2。6±o.3
?
?
?
?
??
?
?
?
?
?
?
?
?
??
?
?
?
?
p1 5。4-    p1 6.1_
■SOZtte  、isOzyme
p1 6。5-   P1 7.4-    p1 7.8-
■sozyme   ■sozyme    ■sOzymご
(U)
0
0
(U) (U)
1。9 ± 0.2  14.9 1 4.6
0。9
4。1
0。2
0.9
0。4 1 o.l   o。9 + o.3
0.4 ± oe1   0。9 1 o。3
0。9 1 0.2  2.9 1 0。1
a) 1hゞen rats 、ゞere decapitated, the ratios in 、ゞeight or thё tumor tO the wh01e bOdy lllere from 7 % t0 13
ヽゞas seen between the ■ncreases Of the ratiO and the spec■f c ctiv■y.  One exper■ment was carr■ed
of a rat of the ratio = 20% ; thb speciFic aCtivity of pyruvate kinase was approximately ono_half that
rat liver; P1 5.4…isOzyme 19as not detectable, P1 6.1-isozyme increased by approximately t、Oゞ tinos, and
%.
out
NO regularity
、ゞith the liver
of normal
noither p1 7.4-
isozyme nor p1 7.8-iso7.yme・were chang d.
●__        ●_                 ● ●
Table IVo   ffect Of lnjectiOn ■ntO Rats oF ChrOmatins Prepared frOm Rhodam■ne
Sarcoma Tissue on Catalase Activity Of Livers.
Tissues Number ofl animals
tested
Catala晏
:::itiVi:二
e, 。f tiSSues
Liver frOm normal
Liver frOm nOrma■
inJected with Rh.
chromatins
Rhodam■ne sarcOma
rat
rat
sarcoma―
3。03 1 0。43
2。29 1 0。27
0
●｀
←
/゛
● Fig。 1。   Isoelectric fractionation of pyruvate kinase present in extracts
from var■ous tissues of rats
Extracts of various tissues (l ml each)were individually subjected to iso―
electric fractionation.  Ampholine―carrier ampholyte (LKB―Produkter,AB., Stock―
holm―Bromma)of PI frOm 3 to 10 were used at a final concentration of l % (w/v).
The electrolysis was carried out for 42 hr at O-1° in a l10-ml electrofocusing
column, and then, the column content was eluted.  The eluate was div■ded into
l―ml fractions.  The pH and the activity of pyruvate kinase (u/ml)were measured
of each fraction。  Open c■rcles, liver of normal rat; closed c■rc es, liver Of
Rhodamine sarcoma―bearing rat (tumor/bOdy = 13 %): open squares, spleen of
normal rat, open triangles, skeletal muscle of normal rat; closed triangles,
kidney of normal rate
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Fig. 2。  Effect of high carbohydrate diet and starvation on ■sOzyme pattern
of pyruvate kinase ■n rat liver
Open c■rcles, rat fed on high carbohydrate diet; closed C■rcles, rat fed on
laboratory diet, open tr■angles, rat starved for 24 hr.
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Fig。 3
ADDENDUM
Effect of injection Of spleen chromatins On isozyme pattern of pyruvate
kinase in liver of normal rat
00
ChrOmatins were prepared from spleen of normal rat accOrding to the method
of Dingman and spOrn w■th s me modificationso  The chromatin preparation was
analyzed to cOntain 3.9 mg/ml of DNA and 9。O mg protein.  It (2。5 ml)was
injected intO the subcutaneous region On the back Of each rato  For the control,
2.5 ml of NaCl solution was injected.  The injected rats were kept for 24 hr
w■th unlim■ted supply of water and diet.  They were then decapitated, and the■r
livers were dissected out and used.
Dingman, C。, Sporn, M., J. Biol. Chem。, 239, 3483 (1964)
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PURIFICAT10N AND PROPERTIES OF M2~IIYPE PYRUVATE KINASE FROM RHODAMINE SARCOMA
by
Tosikazu NAKAMURA
It was previously reported ll)that the pyruvate kinase present in extracts
from various tissues of rats is easily separable into five pI¨isozymes by means
of isoelectric fractionation; their isoelectric points (pI)are 5。4, 6.1, 6。5,
7.4 and 7。8, and the■r kinetic character■stics a e different from one another.
Nakamura elυl′11)have repOrted that when a preparation of chromatins from
Rhodam■ne sarcoma ■s injected intO rats, the activ■ty of pyruvate kinase ■n the
livers ■ncreases to a sign■ficant extent; approx■mately 60% of the ■ncreas d
activity is due to the p1 7.3-iSOZyme, the remainder due to the p1 6。1-isozym .
The present paper deals w■th studie on the pur■fication and properties of
M2~type (p1 7.8-isozyme)pyruvate kinase from Rhodamine sarcoma.
Pur■ficatioLoL当2-■里 ttruvat壁KinasLfrOm Rhodam■ne sarcoma
Rhodamine sarcoma tissues at frozen state (400 g in wet weight)were homo―
genized in 6 volumes (v/w)of O.25 M sucrose solution containing l mM EDTA and
10 mM β―mercaptoethanOl with the use of a Waring blendor.  The homogenate was
centrifuged at 9,009三 fOr 30 mine  The resulting supernatant is called ‖extract".
The extract was supplemented with 277 g/1 of ammOnium sulfate (45% in
saturation)and a110wed to stand fOr half an hour, followed by centrifugation
at 9,000豊for 20 min.  The resulting supernatant was further supplemented with
472 g/1 0f ammOnium sulfate (70% in saturation)and a1lowed to Stand for an
hour, fol10wed by centrifugationo  The resulting precipitate was dissolved in
●
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100 ml of O。25 M sucrose solution containing l mM EDTA and 10 甲配tβ―mercaptoethanol,
and the solution was dialyzed against an excess volume of O.25 M sucrose solution
conta■n■ng l mMbEDTA and 10 mM β―mercaptoethanol.
The dialyzed solution (A280 nmイml = 96)was passed through a column of
phosphocellulose (diameter, 5 cm; length, 50 cm), previously equilibrated with
O.25 M sucrose solution conta■n■ng l muへEDTA and 10 mM β―mercaptoethanolo  The
charged column was washed w■th l lit r of O。25QM sucrose solution conta■n■ng l mM
EDTA and 10 mM β―mercaptoethanol.  Most of the enzyme activ■ty was by―passed。
The by―passed solution (A280 n耐イml = 9075)was supplemented with such a volume
of O。5 M Tris―HCl buffer (pH 7。5)that the buffer concentration of the resulting
mixture would be 20 mM.  The mixture was then passed through a column of DEAE
Sephadex A-50 (dianeter, 5。O cm; length, 50 cm), previously equilibrated with
20 mM Tris―HCl buffer(pH 7.5)containing O.25Mもsucrose,1咄EDTA and■0哩
β―merCaptoethanolo  All the enzyme was adsorbed on the column.  The charged column
was washed with l liter of the buffer used for the equilibrationo  Nearly all
the enzyme was then eluted with l liter of 20 mM Tris―HCl buffer (pH 7.5)containing
O。3ュKCl,0.25ュsucrOSe,1咄EDTA and 10咄β―merCaptoethanol(Fig。1).
The resulting eluate (A280 nmイml =・・25)was supplemented with 350 g/1
of ammonium sulfate (55% in saturation)and allowed to stand for half an hour,
followed by centrifugation at 15,000旦fOr 20 mino  The resulting supernatant was
further supplement with 472 g/1 of ammOnium sulfate (70% in saturation)and
a1lowed to stand for l hr, followed by centr■fugation.The resulting precipitate
was dissolved in 5 ml of O.25 M sucrose conta■n■ng l■関しEDTA and 10 mM β―mercapto―
ethanol, and the solution was dialyzed for overnight aga■nst an excess olume
of O.25 M sucrose solution containing l lMI EDTA and 10 mttt β―mercaptoethanol。
暉
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The dialyzed solution was centrifuged at 15,000豊 fOr 20 min to remove the precipitate
formed during the period of dialysis.
The resulting clear supernatant (A280 nm/ml = 35)waS Subjected to isoelectric
fractionation with Ampholine carrier ampholytes of the range of pH from 6 to 8
(Fig。 2).  The enzyme was in most part collected in fractions, the pH values of
which were centered to 7。8。  Of he fractions, those show■g relatively high
specific activities of pyruvate kinase (No。 36 to No。39 in Fig。2)were mixed,
and the m■xture was concentrated to 3 ml w■th the use of a collodion bag under
a reduced pressure.
The concentrated solution (3 ml) (A280 nm/ml = 0.86)was passed through a
column of Sephadex G-200 (diameter, 2.5 cm; length, 90 cm)previously equilibrated
with O.05ルtris―HCl buffer(pH 7。5)containing O。15ュKC l,l mM EDTA and 10哩
β―merCaptoethanol.  The column was then developed w■th the buffer at a flo  rate
of 24 m1/hr, and the eluate was divided into 5-ml fractions.  The fractions were
measured of protein cOntent and pyruvate kinase activity (Fig。 3).  Fractions
from No。 42 to No。50 were m■xed, and the m■x ure was concentrated into l ml
w■th the use of a collodion bag under a reduced pressure.
All the procedures were carried out in a cold room (approximately 4 )
Yield, Specific Activity and Purity of Purified Preparation of M2 Type Pyruvate
Kinase
The yields and specific activities of preparation of pyruvate kinase obtained
at the preparation procedure descr■bed above ar  summar■zed in Table I.  The
purest preparation of M2~type pyruvate kinase was approximately 2,500 tines as
high in specific activity as the extract,and catalyzed the conversion of 250
μmoles of phOsphoenolpyruvate ■nto pyruvate/A280 nmイm・n. Whe  ■t was subjected
due to pyruvate kinase
‐
●
to polyacrylam■de gel electrophores■s, only a s■ngle band
(4)
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protein was detectable (Fig. 4).  When it was subjected to isoelectric fractiOnation
with Ampholine carrier ampholyte5, the activity of pyruvate kinase was all electro―
focused in one group of fractions, the pH values of which were centered at 7.8.
When it was subjected to Biuret reaction, it was determined that one unit of A280 nm
is equivalent to O.67 mg of the proteino  The aqueous solution of pure pyruvate
kinase was colorless; the absorbance spectrum of the enzyme had a maximum at 280 nm.
Molecular Weight of Purified Pyruvate Kinase
A pure preparation of pyruvate kinase and the marker prote■ns were subjected
to molecular―sieve fractionation on a Sephadex G.200 column in order to determine
the molecular weight of the enzyme (Fig. 5).  It was fOund that the molecular
weight of M2~type pyruvate kinase was approximately l12,000, which was approximately
one half Of the molecular weight Of Ml―type pyruvate kinase (Fig. 6).
The molecular weight of the dissociated M2~type pyruvate kinase was determined
to be approximately 58,000 by means of polyacrylanide electrophoresis in the
presence of sodium dodecyl sulfate.  This indicates that M2~type pyruvate kinase
is present as a dimmer (Fig。7).
As shOwn in Fig. 8, M2~type pyruvate kinase is most active around pH 6。6,
whereas Ml type pyruvate kinase around pH 7。0。
M2~type pyruvate kinase shows an sbsolute requirement of divalent cation
for exhibition of the activ■tyo  The effect of Mg ttcOncentration on enzyme activ■ty
is given in Fig。 9.  The enzyme displays a sigmoidal kinetics toward Mg2+;
the concentrations of Mg + requ■red for exhibition of 50% of the max■mum rate
‐
Effect of Cations on Activitv of Purifiedruvate Kinas
(5)
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are 2.2 ■ltand O・8 mM in the presence of O.5 興認tand 5。O mM phosphoenolpyruvate,
respectivelyo  The Hill coefficient value is 2。2 in the presenc of O。5 mM
phosphoenolpyruvate and l。7 in the presence of 5。O mM the substrate。
Mg + can be replaced by Mn +, but not by Ca +.
pyruvate kinase toward Mn + in the presence of
was significantly different from that for Mg2+
the Km value for the substrate ■n the presence
presence of Mg +.
The kinetic ehavior of M2~type
O.5 mM and 5.O mM phosphoenolpyruvate
(Fige 10).  I seems likely that
of Mn2+ is lower than that in the
←
Effect of PhosDhOen01ruvat  Concentrations on Activ■v of Pur■fi ed
Pyruvate Kinase
lt was found that the p1 7.8-isoZyme (M2~type)of pyruvate kinase purified
from Rhodam■ne sarcoma by isoelectr■c fractionation was hardly stimulated by
fructose l,6-diphosphate, ■n sp■te of that the curve for initial rate興
phosphoenolpyruvate concentration was of a sigmoid shape (n = 1。4); the 'lapparent'1
Km value for phosphoenolpyruvate (the substrate concentration for half the maXimum
rate)was as high as l m醐Lll)
The effect of phosphoenolpyruvate on
kinase ■n presence and absence of O。1 咄
Fig. 11。
The curves for ■n■tial rate versus phosphoenolpyruvate concentration ■s of
一a sigmoid shape and "apparent'l Km value for phosphoenolpyruvate is O。6 興】t with
Hill constant (n)= 1.5 both in the presence and absence of O.1 理型′fructose l,6-
diphosphate (Fig。 12).
1119Ct Of Fructose l,6-diphosphate Concentrations on Activity of Purified
activity of purified M2~type pyruvate
fructose l,6-diphosphate is shown in
●
゛(6)
Fig。 13 shows plots of the effect by fructose l,6-diphosphate as a function
of the concentration of fructose l,6-diphosphate in the presence of either O。5 mM
or 5。0 聖I"phOSphoenolpyruvate.   Fructose l,6-diphosphate shows no effect on
the activ■y of M2 type pyruvate kinase ■n the same manner as on the activ■ty
of Ml type pyruvate kinase.
Effect of ATP Concentrations Activity of Purifiedruvate Kinase
It was reported by Tanaka et alメ13)that the cOncentration of ATP required
for 50%―inhibition of the activity of L―type pyruvate kinase was O.15 円認し whiCh
was approximately ノ20 of that of Ml―type enzyme (3。5 mM)and that the inhibition
of the activ■ty of L―type pyruvate kinase by ATP was neutralized by adding fructose
l,6-diphosphate.  Curves of enzyme activ■ty as a function of ATP―Mg concentration
■n the presence and absence of O.1 1認ぃfructose l,6-diphosphate are shoWn ■n Fig.14.
In the presence of e■ther O.5 mM or 5。O mM phosphoenolpyruvate, 3 1M口ATP depressed
the activity of M2 type pyruvate kinase to 50%.  The neutraliZation of the ATP
inhibition by fructose l,6-diphosphate, which has been observed for L―type enzyme,
is not,observed for M2~type enzymeo  The inhibition by ATP―Mg f M2~type pyruvate
kinas」
'ど
fmost the same as that of Ml type enzyme.
Effect of L―Alan■e Concentrations on Activ■tv of Pur■fi ed ruva te
Kinase
Jimёnez de Asta et al. )have shown that M―typ pyruva e kinase from
skeletal muscle (Ml―typ )is inhibited by宅Zhenylalanine, but not by L―alanine,
whereas that from liver (M2~type)either by ■
「
phenylalanine or by L―alanine。
Curves of the activ■ty of M2 type pyruvate kinase as a function of L―alan■e
are shown in Fig。15.  The shape of the inhibition curves is of the Michaelis―
Menten type.  In the presence of O。5 mM and 5.0 1聟げphOSphoenolpyruvate, 0。1 咄
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(7)
and O。7 ■聖´L―alanine, respectively, g■ve 50%―inhibitiono  The extent of the
■nhibition by L―alan■e reach a max■mum t 3 mM.L―alan■e; the max■mum extent
is s■gnificantly with o。5 mM than with 5.0 口ょ^ phOSphoenolpyruvateo  The type of
■nhibition of M2 type pyruvate kinase by L―alan■e ■s of the type of the partial
competing inhibition, which have been proposed by Gerhart and Pardee6)。n the
bas■s of the■r studies on aspartate trarlscarbamylase; the L―alan■e ■nhibition
may be caused by the binding of L―alan■e w■th an alloster■c s■te。
The addition of fructose l,6-diphosphate greatly lowers both the maximum
extent of the ■nhibition by ■ralan■e and the concentration of L―alan■e
required for the maximum extent of the inhibitiono  This suggests that L―alan ne
and fructose l,6-diphosphate binds w■th a common binding s■te.
●
●(8)
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Table I  Pur■fication of M2 Type Pyruvate Kinase from Rhodam■ne sarcoma
Procedures              VOlume    Concentration   Total un■ts    Prote■n      Spec■fic activ■y  Yield  Pur■ficatioFl
(ml)   (units/ml)         (A280n/ml) (unitS/A280nm) (%)
Extract                 2,000          4。40     8,890          43.5             0.100        100           1
45-70% ammonium sulfate
fractionation             146         38。1         5,560           96.0             0.397         63           4
P―cellulose               450          9。69    4,360           9。75    0。994        49          10
DEAE―sephadex A-50        900          4.68        4,210            1.25            3.75          47          38
55-70% ammonium sulfate
fractionation              15.4      242           3,720           35。0    6。91      42   69
Electrofocus■ng by
Ampholine―carrier ampholyte28。5       96.5         2,750            0.857         113             31       1,130
Sephadex G-200             47。0  47.0         2,210            0.188         250             25       2,500
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Fig. 1Chromatography
from Rhodamine
on DEAE―Sephadex
s rcoma
A-50 column of M2~type pyruvate kinase
。?C,!vl,ソ
??
?‐
‐
‐
‐
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‐
‐
?
．
?
/A200 nm
:0             20
F『oc,:ons tiO m1 0oCh)
The activ■y of pyruvate kinase was measured according to the method of
Bticher and Pfleiderere 3)  The standard reaction mixture was composed of O.5 ml
of O.1 lM、TriS―HCl buffer (pH 7.5), 0.l ml of 20 1v゛phOSphoenolpyruvate, 0.l ml
of 20咄ADP,0。l m1 0f l。5ュKCl,50■l of O。2ュM∫12'50,l of 5咄NADH,
10■l of 150-200 units/ml of lactate dehydrogenase (D―lactate:NAD+ xidor ductase,
DC l。1 1。28)and water to make the total volume l。O ml.  The reaction was started
by adding 10 or 20 ■1 0f enzyme sample to the standard reaction m■xture, and the
decrease of absorbancy at 340 nm was measured at 24 。  One un■t of pyruvat  kinase
was difined as the amount of the enzyme that caused the oxidation of l llmole of
NADH per min。
40
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Fig. 2  1sOelectr■c fractionation of M2 type pyruvate kinase
8
7 エ
6
5
4
Froctions(2 ml ooch)
Isoelectric fractionation on an electrofocusing column of M2~type pyruvate
kinase was carr■ed out according to the method of Vesterverg and Svensson 14);
the procedure used was the same as that described previously.9'1°'11)
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fractionation on Sephadex G-200 column Of M2~typeFig。 3Molecular s■eve
pyruvate kinase
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Fig. 4  Polyacrylamide gel electrophoresis of purified―type py uvate kinase
一
BPB
Electrophores■s on a column of polyacrylam■de gel Was carr■ed out acCOrding
to the method of Ornste■F2)and Dav■s  ).  The column had on ■nner diameter 5 mm
and a length of 80 mm.  In the column, 0.4 ml of the large―p re gel (2。5%)waS
layered over l。5 ml of the sma11-pore gel (7.5%).   A total of 10 1Lg Of M2~type
pyruvate kinase ■n sucrose dense solution Was applied on the gele  Electrode
buffer carefully layered on top of sample to fill the columno  The electrophores■s
was carried out in O.8 M′Tris―HCl buffer (pH 8.9)at 3 1聟ぉper C°lumn and at 4
for 2.5 hr.  The polyacrylam■de gel was then taken out of the column, and immersed
in a 12.5% trichlorOacetic acid solution for l hr and successively in a staining
solution for l hr.  The staining solution was prepared freshly by a 20-fold dilution
with 12。5% trichlorOacetic acid of the stock solution, 1%CoomSSie Brilliant Blue
4)
(Colab Laboratories lnce,Chicago), as described by Chralnbach et al。  。
The resulting gel was then transferred in a pan conta■n■ng a 12.5% tr■ch10 Oacetic
ac■d solution and a1lowed to stand for two days.  The sta■ing gel was exam■ne
■n the pur■ty of the enzyme preparation applied, and photographed.
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Fig. 5Molecular―s■eve
M2~type pyruvate
fractionation On Sephadex G.200 c01umn of Ml type and
kinase
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Samples (3 ml)were passed upward through a Sephadex G.200 column equipped
with an Upward―F10w adaptor (Pharmacia Fine Chemicals, Uppsala)which was previously
equilibrated by O.05議Tris―HCl buffer(pH 7.5)containing O.1■KC l,10 mM
β―merCaptoethanol and l mM EDTA.  The charged column was developed w■th the same
buffer; the flow rates was adjusted at 24 m1/hr by a Peristalitic pump, type
10,200 (LKB―Produkter AB。, StOckh01m―Bro a).  The eluate from the column was
fractionated into 5 ml aliquots by a fractiOn c01lector.
●
E:u‖on v。:umo(mi)
(15)
●
Fig. 6  Plotting of Ve/Vo against log[molecular weight] in molecular―sieve
fractionation on Sephadex G■200 column of Ml type and M2 type pyruvate
kinases and marker prote■ns
cy,Ochrome c
‐――――――oibum:n
‐――………… M2~'ype
pyruvole
r-9:。buiins―
M:-lype ―………………………Ⅲ
pyruvote kinose
:。
3
・  Mo!ecu!cr.weighl
Of the markers used, apoferritin (molo wt. = 480,000)was eluted at a volume
(Ve)of 175 ml, γ―globulins (mol. wt. = 160,000)at Ve of 235 ml, albumin (mol。
wt. = 67,000)at Ve Of 285 ml and cytochrome c (mole wt. = 12,000)at Ve Of 380 ml.
On the basis of these values, molecular weight of M2~type pyruvate kinase was
calculated approximately according to the description of Andrews. 1)
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●
Fige 7  P01yacrylamide―gel electrophoresis Of purified M2~type pyruvate kinase
and marker prOteins in presence of 80diun dodecyl sulfate
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Acrylamide―gel electrophoresls ■n presence of 80diun dodecyl sulfate and
the pretreatment used for the runs was carried out by the method of Weber and
_       Osborn。
15) Albunin, OvalbunilbaldOlase, glyceraldehyde-3-phosphate dehydrogenase
and chymotrypsinOgen were used as the reference mar=ers fOr the molecular weight
Calibration.  ▲ tOtal of 10■g of M2 type pyruvate kinase was used for electrOphores■s.
(17)
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Fig。 8  Effect of pH on activities of purified Ml―type and M2~type pyruvate
kinage
二 100
The experimental conditiOns were as described in Fig。 1, excepted that a
buffer compOsed of 3,3-dimethylglutarate, Tr■s and 2-am■no-2-methylpropane-1,2-
diol was used and reaction m■xtu s were adjusted to var■ous pH values.
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Fige 9  Effect of Mg + concentrations onactivity of M2~type pyruvate kinase
200
100
4    6
M92●・mM
The experimental conditions were as described in Fig。 1, except that the
concentratiOn of phosphoenolpyruvate was fixed at O。5 型引tor 5。0 回型tand var■Ous
concentrations of Mgc12 Were added to reaction m■xture.
＼ :TmM
O.5 mM
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Fig. 10 of Mn +and Ca +こoncentration8 0nactivity of M2~type pyruvateEffects
kinT:
?．?
H卜♂ "♂,JThe experimental conditions were as described in Fi
concentration oF phosphoenolpyruvate was fixed at O。5 mM
concentratiOns Of MnC12 °
' CaC12 Were added to reaction
lo
hg. 1, except that the
or 5。O mM and var■ous
m■xture.
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Fig。 11Effect of PEP concentrations on
■n presence and absence of FDP
activ■y of M2 type pyruvate kinase
250
200
100
50
PEP,mM
The experimental conditions were the same as those described in Fig. 1っ
except that in the reaction m■xtu  for the activ■ty ssay, the concentration
of ADP was fixed at 2 mM′ whereas the concentration of phosphoenolpyruvate was
var■ed and var■ous concentrations of phosphoenolpyruvate and O。l mM fructose l,6-
diphosphate were added for measurement Of the activation by fructose l,6-diphosphate.
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θ
Fig. 12  Hill's plotting of activity
of PEP concentration
°f M2~type pyruvate kinase as function
????」?‥?。?
Hill
curves of
method of
-0.5      o
10g〔PEP,mM〕
constants (n)for phosphoenolpyruvate were calculated on the basis
activ■ty vso phosphoenolpyruvate concentrations according to the
AtkisOn et al。.2)
Of
◆
+0。ImM FD
(n31。5)
nO Oddition
(n=:。5)
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Fig。 13  Effect of FDP concentrations on activity of M2~type pyruvate kinase
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The experimental conditions were as described in Fig. 1, except that the concentration
of phosphoenolpyruvate was fixed at O。5 mM or 5.O mM and var■ous concentrations
of fructose l,6-diphosphate were added to reaction mixture.
●
(23)
Fig. 14  Effect of ATP cOncentrations on activity of M2~type pyruvate kinase
:50
4     6
M9-ATP,mM
The experimental conditions were as described in Fig。 1, except that the
concentration of phosphoenolpyruvate was fixed at O.5 mM or 5。O mM and var■ous
‐         
“
concentratiOns of Mg―ATP were added to reaction m■xtu e ■n presence and absence
of O。1 1出i fruCtOSe l,6-diphosphate。
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Fig。 15  1nhibition on activity of M2~type pyruvate kinase by L―alanin
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The experimental conditiOns were as described in Fig。 1, except that the
concentration of phosphOenolpyruvate was fixed at O。5 mM or 5。O mM and var■ousW          "
concentratiOns Of L―alan■e were added to reaction m■xture ■n presence and
absence of O。1 1螢r fructose l,6-diphosphate。
